Long-term follow-up of laquinimod in patients with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Comi, G. [1 ,2 ]
Vollmer, T. L. [3 ]
Lublin, F. D. [4 ]
Dadon, Y. [5 ]
Gorfine, T. [5 ]
Davis, M. D. [6 ]
Sorensen, P. S. [7 ]
Knappertz, V. [6 ,8 ]
机构：
[1] Ist Sci San Raffaele, I-20132 Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] Univ Colorado, Aurora, CO USA
[4] Mt Sinai Sch Med, New York, NY USA
[5] Teva Pharmaceut Ind, Netanya, Israel
[6] Teva Pharmaceut, Frazer, PA USA
[7] Danish Multiple Sclerosis Ctr, Copenhagen, Denmark
[8] Univ Dusseldorf, Dusseldorf, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P319
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [1] Long-term follow-up of laquinimod in patients with relapsing-remitting multiple sclerosis
    Comi, G.
    Vollmer, T. L.
    Ashtamker, N.
    Sidi, Y.
    Ladkani, D.
    Gorfine, T.
    Sorensen, P. S.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 39 - 39
  • [2] Long-Term Follow-Up of Laquinimod 0.6 mg in Patients with Relapsing-Remitting Multiple Sclerosis 2
    Comi, Giancarlo
    Vollmer, Timothy
    Lublin, Fred
    Dadon, Yuval
    Gorfine, Tali
    Davis, Mat
    Sorensen, Per Soelberg
    Knappertz, Volker
    NEUROLOGY, 2016, 86
  • [3] Long-term follow-up of immunomodulatory therapies in early relapsing-remitting multiple sclerosis
    Haas, Judith
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S45 - S46
  • [4] Assessing 'no evidence of disease activity' status in patients with relapsing-remitting multiple sclerosis: a long-term follow-up
    Zilli, Chiara
    Rossi, Pietro Scribani
    Di Stadio, Arianna
    Fratino, Mariangela
    Giuliani, Giada
    Annecca, Rosanna
    Russo, Gaetano
    Di Piero, Vittorio
    Altieri, Marta
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [5] Predictive value of the multiple sclerosis functional composite in relapsing-remitting Multiple Sclerosis: Results of a long-term follow-up study
    Rudick, RA
    Cutter, G
    Baier, M
    Dougherty, DS
    Weinstock-Guttman, B
    Mass, MK
    Fisher, E
    Miller, DM
    Simonian, NA
    NEUROLOGY, 2000, 54 (07) : A215 - A215
  • [6] Development of laquinimod for relapsing-remitting multiple sclerosis
    Jeffery, Douglas R.
    FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648
  • [7] Long-term disability outcomes in relapsing-remitting multiple sclerosis: A 10-year follow-up study
    Drulovic, Jelena
    Pekmezovic, Tatjana
    Mesaros, Sarlota
    Dujmovic, Irena
    Martinovic, Vanja
    Ivanovic, Jovana
    Hellwig, Kerstin
    NEUROLOGY, 2018, 90
  • [8] Long-term disability outcomes in relapsing-remitting multiple sclerosis: a 10-year follow-up study
    Jelena Drulovic
    Jovana Ivanovic
    Sarlota Mesaros
    Vanja Martinovic
    Darija Kisic-Tepavcevic
    Irena Dujmovic
    Tatjana Pekmezovic
    Neurological Sciences, 2019, 40 : 1627 - 1636
  • [9] Long-term disability outcomes in relapsing-remitting multiple sclerosis: a 10-year follow-up study
    Drulovic, Jelena
    Ivanovic, Jovana
    Mesaros, Sarlota
    Martinovic, Vanja
    Kisic-Tepavcevic, Darija
    Dujmovic, Irena
    Pekmezovic, Tatjana
    NEUROLOGICAL SCIENCES, 2019, 40 (08) : 1627 - 1636
  • [10] Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis
    Eriksson, M
    Andersen, O
    Runmarker, B
    MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (03) : 260 - 274
12345